Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI Europe ESG Broad Transition UCITS ETF EUR Hedged Acc (C)

CEUH · LU2873560481 · class UCITS ETF EUR Hedged Acc · EUR · domicile Luxembourg
Equity · Europe · All sizes · Sustainable / ESGEUR-hedged share classSFDR art. 8
Index tracked: MSCI Europe ESG Broad CTB Select Index
TER
0.14%+ trans. 0.13%
Fund size
61 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 24 Oct 2024 · costs from the KID as of 2 Sept 2026 · 376 securities held · 7 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The Sub-Fund is a financial product that promotes among other characteristics ESG characteristics pursuant to Article 8 of the Disclosure Regulation. The objective of this Sub-Fund is to track the performance of MSCI Europe ESG Broad CTB Select Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is an…

Performance since series start (in euro) — base 100

1 Nov 20248 Sept 2026 · dividends reinvested where declared by the issuer
2025202613592132
High 135 (10 Aug 2026) · low 92 (9 Apr 2025) · last 132. Past performance is not indicative of future results.

Returns in euro

1 year+20.5%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+32.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.18%12.18%
Max drawdown−10.28%−10.28%
Sharpe1.361.36
Sortino2.082.08
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CEUH · LU28735604811
RebalixCEUH · LU2873560481 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+19.58%+19.34%+0.24%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 376 securities · top-10 weight = 21.4%
Top holdingsWeight
ASML HOLDING NV4.6%
HSBC HOLDINGS PLC2.6%
NOVARTIS AG-REG2.3%
ROCHE HOLDING AG - GENUSSS CHF2.3%
ASTRAZENECA GBP1.8%
ALLIANZ SE-REG1.6%
BANCO SANTANDER SA MADRID1.6%
SAP SE / XETRA1.6%
SIEMENS AG-REG1.5%
SCHNEIDER ELECT SE1.5%
Countries (% of fund)
United Kingdom20.6%France14.7%Switzerland14.5%Germany12.6%Netherlands9.7%
Sectors (% of fund)
Financials26.9%Industrials18.7%Health Care13.5%Information Technology9.3%Consumer Staples7.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
CEUH · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2873560481/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2873560481/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2873560481/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2873560481
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CEUH · LU28735604812